Form 4: Myriad Genetics CTO Receives Stock Grant

Sentiment:

Insider Transaction (Form 4)


Raj Jampa, Chief Technology Officer of Myriad Genetics Inc, received 58,560 shares of common stock on November 6, 2026.

Summary

  • Grant/award: acquired 58,560 Time-Based Stock Option on November 6, 2026; holds 58,560 after (Direct).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.

Insider Transactions

Raj Jampa — Officer (Chief Technology Officer)

DateTransactionSecuritySharesPriceValueHeld After
2026-11-06Grant/awardTime-Based Stock Option58,560——58,560

Key Dates

DateDescription
2026-11-06Grant/award (58,560 shares)

Keywords

insider transaction, Form 4, MYGN, MYRIAD GENETICS INC, neutral, Raj Jampa

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.